SPINREACT

What SPINREACT does

SPINREACT is a Spanish in vitro diagnostics (IVD) manufacturer founded in 1975 in Sant Esteve de Bas, Girona, operating under the TOYOBO Group umbrella and legally registered as SPINREACT S.A.U. The company develops, manufactures, and distributes diagnostic reagents and instruments across clinical biochemistry, immunochemistry, hematology, coagulation, serology, and rapid testing, with proprietary methods anchored by its C-Reactive Protein (PCR-Latex and PCR-Turbilatex) reagents — its flagship product for over 30 years — and the Spincell hematology analyzer line launched in 2017. Its technology stack centers on classical IVD methodologies including latex agglutination, turbidimetry, carbon particle agglutination, photometry, ion-selective electrode measurement, and automated cell counting, supported by ISO 13485:2016, ISO 9001:2015, ISO 14001:2015, and IVDR-certified quality systems. The company monetizes through a channel-partner go-to-market model, selling exclusively via a global distributor network spanning over 120 countries and reaching mid-market clinical laboratories and law enforcement agencies worldwide; revenue streams combine one-time reagent and instrument sales with recurring reagent consumption tied to installed instrument bases.

Name

SPINREACT

Legal name

SPINREACT S.A.U.

Website

https://spinreact.com

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

101–250 employees

Short description

SPINREACT is a Spanish in vitro diagnostics manufacturer founded in 1975, producing clinical biochemistry reagents, hematology and biochemistry instruments, serology tests, and rapid diagnostics for clinical laboratories and distributors across 120+ countries under the TOYOBO Group umbrella.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Pharmaceutical Preparations (2834)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL)

Keywords

• In vitro diagnostics
• Clinical chemistry reagents
• Hematology analyzers
• Immunochemistry reagents
• Diagnostic instruments

Headquarters

HQ city

Girona

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. IVD Reagents: Sale of diagnostic reagents for clinical biochemistry, immunochemistry, serology, coagulation, hematology, and rapid tests. Products include clinical chemistry reagents, immunoturbidimetry reagents, and dedicated line reagents for various automated analyzers.
2. Laboratory Instruments: Manufacturing and sale of diagnostic instruments including hematology analyzers (Spincell line), semi-automatic and automatic biochemical analyzers (Spinlab S, Spin XS, Spin 230, Spin 360E, Spin 640plus, Spin 800, Spin XL), coagulation analyzers (Biobas), urine strip readers (Urispin), and ISE analyzers (e-Spin10).
3. Micropipettes and Accessories: Sale of laboratory equipment including fixed and adjustable volume autoclavable micropipettes and accessories.
4. Quality Control Products: Sale of calibrators and controls for coagulation, biochemistry, and hematology testing to ensure laboratory quality assurance.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

SPINREACT develops, manufactures, and distributes in vitro diagnostic (IVD) reagents and analytical instruments for clinical laboratories worldwide. The product portfolio covers clinical biochemistry, immunochemistry, hematology, coagulation, serology, rapid tests, and drugs of abuse testing, complemented by proprietary analyzer lines such as the Spincell hematology series and Spinlab biochemistry analyzers. The company sells primarily through an international distributor network active in more than 120 countries.

Product overview

SPINREACT is an in vitro diagnostics (IVD) company specializing in diagnostic solutions for laboratories. Founded in 1975, the company offers a comprehensive portfolio of products organized into key categories: Clinical Biochemistry Reagents (substrates, electrolytes, lipids, enzymes, calibrators), Immunochemistry (immunoturbidimetry, turbilatex reagents), Hematology/Hemostasia (Spincell analyzer line with 3-part and 5-part models, reagents and controls), Coagulation (reagents, Biobas instruments), Serology (rheumatoid diagnostics, syphilis diagnostics), Rapid Tests (one-step tests for drugs of abuse, infectious diseases, cardiac markers), Drugs of Abuse (liquid reagents and rapid tests), and Instruments (semi-automatic and automatic analyzers including Spinlab S, Spin XL, Spin 360E, Spin 230, Spin 640 Plus, Spin 800, Spincell hematology analyzers, Biobas coagulation analyzers, e-Spin10 ISE analyzer, Urispin urine readers). The company also provides Micropipettes and Dedicated Lines (reagents optimized for specific third-party analyzer systems). Notable flagship products include C-Reactive Protein (PCR), which has been the best-selling product for 30 years, and the RPR-Carbon syphilis test. SPINREACT has recently expanded into instrument manufacturing with the Spincell hematology line launched in 2017, and continues to develop new analyzers like the Spin XL.

Differentiator

Problem solved

Functional benefit

Brands

• Spinlab: Semi-automatic biochemical analyzer product line
• Spincell
• Spin XL
• Spin 360E
• Spin 230
• SpinXS
• e-Spin10
• Biobas
• Urispin

Products and services

• Clinical Biochemistry Reagents
• Immunochemistry Reagents
• Hematology Reagents
• Coagulation Reagents
• Serology Reagents
• Rapid Tests (One Step)
• Drugs of Abuse Tests
• Dedicated Lines (Third-Party Compatible Reagents)
• Spincell Hematology Analyzer Family
• Spinlab Biochemistry Analyzer Family
• Biobas Coagulation Analyzers
• Urispin Urine Strip Reader
• e-Spin10 ISE Electrolyte Analyzer
• Micropipettes

Quantifiable outcome

• Spinreact is one of the largest PCR (C-reactive protein) reagent manufacturers worldwide, with 6 samples analyzed per second globally
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• TOYOBO GroupcoreStrategic or Co-development Partner · 1 January 1975TOYOBO Group is the parent company of Spinreact. Spinreact has been monitoring the health of people since 1975 under the TOYOBO Group umbrella. This affiliation provides strategic backing for Spinreact's IVD operations.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ELITechGroup: European mid-sized IVD company focused on clinical chemistry reagents and instruments, with a comparable product breadth across clinical biochemistry, serology, and hematology, and a similar distributor-led go-to-market model in emerging markets.
• Horiba Medical: Mid-sized European IVD player with a strong hematology instrument line and clinical chemistry reagents, directly overlapping Spinreact's Spincell hematology and clinical biochemistry offerings.
• Randox Laboratories: Independent European IVD manufacturer of reagents and analyzers across clinical chemistry, immunoassay, and hematology, with comparable scale, distributor model, and reagent-led catalog to Spinreact.

Broad incumbents

• BioMérieux: Global IVD leader with broad microbiology, immunoassay, and clinical chemistry reagent portfolios, representing the tier Spinreact competes against for reagent contracts and instrument placements worldwide.
• Sysmex Corporation: Global hematology and IVD incumbent, dominant in hematology analyzers and reagents, sitting directly against Spinreact's Spincell line and hematology reagents.
• Mindray: Large IVD and medical device manufacturer with broad clinical chemistry and hematology analyzer lines, a key competitor for mid-tier laboratories and emerging markets where Spinreact also competes.
• ABBOTT Diagnostics: Global IVD major across clinical chemistry, immunoassay, and point-of-care, benchmark competitor for hospital labs where Spinreact's customers also evaluate Spinlab/Spincell systems.

Regional players

• Diagnostic Grifols: Iberian (Spanish) diagnostics and blood-screening manufacturer focused on transfusion and clinical diagnostics, with overlapping IVD reagent capability and shared Iberian heritage to Spinreact.

Emerging players

• Tokyo Boeki (Tokyo Boeki Medisys): Japanese IVD reagent and analyzer brand referenced in Spinreact's own 'Dedicated Lines' compatibility list, indicating shared instrument reagent-channel partnerships in Asian and emerging markets.
• Teco Diagnostics: Mid-sized reagent manufacturer of clinical chemistry and serology reagents with a distributor-heavy emerging-market footprint comparable to Spinreact's go-to-market profile.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/spinreact
• Facebookfacebook.com/spinreact

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SPINREACT